Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 3/2011

01-03-2011 | Case Report

Mycobacterium fortuitum Infections Associated with Laparoscopic Gastric Banding

Authors: Erin C. Callen, Tiffany L. Kessler

Published in: Obesity Surgery | Issue 3/2011

Login to get access

Abstract

Mycobacterium fortuitum, a rapidly growing atypical mycobacteria, is commonly found in soil and water. This organism is most often known to cause skin, bone, and soft tissue infections associated with local trauma, surgical procedures, and in patients with immunodeficiency. Nosocomial infections associated with a variety of contaminated devices and equipment have also been widely documented. This report presents the first cases of M. fortuitum infection following laparoscopic gastric banding procedures. Both patients had complicated clinical courses necessitating removal of their banding devices and long-term antibiotic therapy.
Literature
1.
2.
American Thoracic Society. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial disease. Am J Respir Crit Care Med. 2007;175:367–416.CrossRef
3.
Herold RC, Lotke PA, MacGregor RR. Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin Orthop Relat Res. 1987;216:183–7.PubMed
4.
Hemmersbach-Miller M, Cardenes-Santana M, Conde-Martel A, et al. Cardiac device infections due to Mycobacterium fortuitum. Can J Infect Dis Med Microbiol. 2005;16:183–4.PubMed
5.
Hoy JF, Rolston KV, Hopfer RF, et al. Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. Am J Med. 1987;83:213–7.CrossRefPubMed
6.
Phillips MS, von Reyn CF. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis. 2001;33:1363–74.CrossRefPubMed
7.
Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of pathogenic non-pigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15:716–46.CrossRefPubMed
8.
Hoffman PC, Fraser DW, Robiesek F, et al. Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex. J Infect Dis. 1981;143:533–42.PubMed
9.
Wallace RJ, Steele LC, Labidi A, et al. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammoplasty despite case clustering in Texas and other southern coastal states. J Infect Dis. 1989;160:281–8.PubMed
10.
Swenson JM, Wallace RJ, Silcox VA, et al. Antimicrobial susceptibility testing of 5 subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985;28:807–11.PubMed
11.
Patel JB, Leonard D, Pan X, et al. Sequence-based identification of Mycobacterium species using the MicroSeq 50016S rDNA bacterial identification system. J Clin Microbiol. 2000;38:246–51.PubMed
12.
Turenne CY, Tshetter L, Wolfe J, et al. Necessity of quality controlled 16S rRNA gene sequence databases: identifying nontuberculous mycobacterial species. J Clin Microbiol. 2001;39:3637–48.CrossRefPubMed
13.
Bueter M, Maroske J, Thalheimer A, et al. Short- and long-term results of laparoscopic gastric banding for morbid obesity. Langenbecks Arch Surg. 2008;393:199–205.CrossRefPubMed
14.
Martin LF, Smits GJ, Greenstein RJ. Treating morbid obesity with laparoscopic adjustable gastric banding. Am J Surg. 2007;194:333–43.CrossRefPubMed
15.
Susmallian S, Ezri T, Elis M, et al. Access-port complications after laparoscopic gastric banding. Obes Surg. 2003;13:128–31.CrossRefPubMed
16.
Abu-Abeid S, Keidar A, Gavert N, et al. The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc. 2003;17:861–3.CrossRefPubMed
Metadata
Title
Mycobacterium fortuitum Infections Associated with Laparoscopic Gastric Banding
Authors
Erin C. Callen
Tiffany L. Kessler
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 3/2011
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-010-0123-1

Other articles of this Issue 3/2011

Obesity Surgery 3/2011 Go to the issue

Clinical Research

NAFLD and Insulin Resistance Do Not Increase the Risk of Postoperative Complications Among Patients Undergoing Bariatric Surgery—A Prospective Analysis

Short Communication

Bariatric Surgery is Associated with Reduced Depressive Symptoms and Better Sexual Function in Obese Female Patients: A One-Year Follow-Up Study

Clinical Research

Patients’ Experience of Surplus Skin After Laparoscopic Gastric Bypass

Clinical Report

Preliminary Surgical Results of Single-Incision Transumbilical Laparoscopic Bariatric Surgery

Clinical Research

Obstructive Sleep Apnea in Patients Undergoing Bariatric Surgery—A Tertiary Center Experience

Erratum

Erratum: Erosive Esophagitis after Bariatric Surgery: Banded Vertical Gastrectomy versus Banded Roux-en-Y Gastric Bypass